Acute Coronary Syndrome Following Long-Term Erlotinib Treatment Cover

.blurhash-client-img { display: none !important; }

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Internal Medicine

Volume 15 (2018): Issue 3 (July 2018)

By: Traian Constantin Panciu, Bianca Masgras, Catrinel Ciuca, Raluca Ciomag, Anca Mihăilescu and Adriana Gurghean

Open Access

|Jul 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/inmed-2018-0023 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818

Journal RSS Feed

Language: English

Page range: 61 - 66

Published on: Jul 20, 2018

Published by: Romanian Society of Internal Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

tyrosine kinase inhibitor,

non-small cell lung cancer,

acute coronary syndrome

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2018 Traian Constantin Panciu, Bianca Masgras, Catrinel Ciuca, Raluca Ciomag, Anca Mihăilescu, Adriana Gurghean, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 15 (2018): Issue 3 (July 2018)Next article